BioCardia公布Cardiamp心力衰竭试验超声心动图最新数据,将于技术与心力衰竭治疗大会发布

美股速递
Feb 03

生物医药企业BioCardia宣布,其Cardiamp心力衰竭临床试验的突破性超声心动图研究结果,已被遴选为"技术与心力衰竭治疗大会"(THT)的压轴报告内容。该项晚期研究数据旨在通过先进影像学评估细胞疗法对心功能的重塑效果,为心力衰竭治疗领域提供新的临床证据。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10